Skip to content

Author

S. Erhamamcı

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Baseline 18F-FDG PET/CT-derived heterogeneity index predicts poor pathological response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Baseline 18F-FDG PET/CT-derived HI, MTV, and TLG may help identify LARC patients at risk for Ryan 3 poor pathological response and the workstation-calculable HI may provide complementary information for pretreatment risk stratification.

Yiğithan Okar, Ö. Şahin, S. Erhamamcı et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.